OpenAlex
PricingAboutJobs
Log inGet started
Work

Cetuximab plus FOLFIRI: Final data from the CRYSTAL study on the association of KRAS and BRAF biomarker status with treatment outcome.

HTML

Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2010.28.15_suppl.3570
Authors: E. Van Cutsem, I. Lang, G. Folprecht, M. Nowacki, C. Barone, I. Shchepotin, J. Maurel, D. Cunningham, I. Celik, C. Kohne
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: cetuximab, FOLFIRI, metastatic colorectal cancer, KRAS mutation status, BRAF mutation status, predictive biomarkers, first-line therapy, CRYSTAL trial, overall survival, treatment response, EGFR inhibition
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2591284091
Cites:
Cited by: 71
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security